E-MAIL   PASSWORD Forgot password?New user?
Hematology/Oncology

RFA is an effective alternative to lobectomy for lung cancer

Scott Cackler, PA-C; Ghulam Abbas, MD

 

Approximately 213 380 new cases of lung cancer are diagnosed annually in the United States; as a result, lung cancer continues to be the leading cause of cancer-related deaths in both men and women. Surgical lobar resection with systematic hilar and mediastinal lymph node dissection offers the best opportunity for cure and is the standard treatment for early-stage non-small cell lung cancer (NSCLC). Unfortunately, numerous patients with resectable early-stage disease are unable to tolerate pulmonary resection. Compromised cardiopulmonary function or medical comorbidities may make patients unsuitable candidates for the procedure.

jaapa.gif delivers a wide range of clinical topics. Visit JAAPA.com

    Where do you see pharmacologic therapy fitting into integrative oncology treatment?

    Medical Crossfire Hematology/Oncology, Mar 2010

    What is integrative oncology?

    Medical Crossfire Hematology/Oncology, Mar 2010

    RFA is an effective alternative to lobectomy for lung cancer

    Medical Crossfire Surgery, Jun 2009

    VATS lobectomy to treat early-stage non-small cell lung cancer

    Medical Crossfire Surgery, Jun 2009

    Human papillomavirus infection and the HPV vaccine: what are the facts?

    Medical Crossfire Women's Health, Jun 2009

    Breast meeting brings wide-ranging news

    Medical Crossfire Women's Health, Jun 2009

     
    Page 1 2 3 

    Women's Health / Gynecology

    Also In Global Health News: Congo Security Warnings; Niger Food Crisis; Drug Cost In Developing Countries; Measles Vaccination In China
    Fri, 03 Sep 2010 06:00:00 PDT

    Cancer / Oncology

    Celsion Receives SBIR Grant To Expand Its Technology Platform
    Fri, 03 Sep 2010 05:00:00 PDT
    View more >>

    • What are the benefits of integrative oncology?

      Drs. Donald I. Abrams, Kara Kelly and Stephen Sagar highlight the benefits of integrative oncology.

      Preview Program: What are the benefits of integrative oncology?

      Why are complementary therapies important for cancer patients?

      Drs. David Servan-Schreiber, Lorenzo Cohen, and Barrie Cassileth tell us why complementary therapies matter so much to cancer patients.

      Preview Program: Why are complementary therapies important for cancer patients?

    • What has science got to do with integrative oncology practice?

      Drs. Dean Ornish, Kara Kelly, and Donald I. Abrams discuss the relationship between science and integrative oncology.

      Preview Program: What has science got to do with integrative oncology practice?

      Are there economic advantages?

      Drs. David Rosenthal, Lorenzo Cohen, and David Servan-Schreiber go over the economic advantages of integrative oncology.

      Preview Program: Are there economic advantages?

    • What role does integrative oncology have in healthcare change?

      Drs. Dean Ornish, David Rosenthal, and Kara Kelly comment on the role of integrative oncology in healthcare change.

      Preview Program: What role does integrative oncology have in healthcare change?

      Tell me about the Society for Integrative Oncology?

      Drs. Stephen Sagar, David Rosenthal, and Kara Kelly provide information on Society for Integrative Oncology.

      Preview Program: Tell me about the Society for Integrative Oncology?

    • Where do you see pharmacologic therapy fitting into integrative oncology treatment?

      Drs. Stephen Sagar, David Servan-Schreiber, and Lorenzo Cohen share their views on where they see pharmacologic therapy fitting into integrative oncology treatment.

      Preview Program: Where do you see pharmacologic therapy fitting into integrative oncology treatment?

      What is integrative oncology?

      Drs. David Rosenthal, Barrie Cassileth, and Dean Ornish elaborate upon the term integrative oncology and what it means.

      Preview Program: What is integrative oncology?

    • VATS lobectomy to treat early-stage non-small cell lung cancer

      The bad news is that in 2008, lung cancer still remains the leading cause of cancer deaths in the United States: almost 162 000 deaths are expected and more than 200 000 new cases are anticipated this year alone. The good news is that as screening mo...

      Human papillomavirus infection and the HPV vaccine: what are the facts?

      Human papillomavirus (HPV) causes the most common sexually transmitted infection (STI) in the United States. Approximately 20 million people are currently infected with HPV, with 6.2 million people acquiring it each year. Estimates are that more than...

    • Breast meeting brings wide-ranging news

      High-dose, extended-duration chemotherapy offers no advantages over standard regimens for preventing recu...

      Vaccines offer a potential new therapy for ovarian cancer

      Ovarian cancer kills approximately 15 250 women annually in the United States. Most pati...

    • A serious condition or a benign masquerade?

      What's the best sun protection to use?

      The adverse effects of UV ra...

    • A worrisome, increasingly painful breast mass in an adolescent female

      A 16-year-old female presented to a family medicine clinic for evaluatio...